Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Frölich

Showing results (81-90 of 92) with videos related to

Pageof 10
Sort By:
The Journal of Prevention of Alzheimer'S Disease|December 13, 2017
Results from a Phase II Study to Assess the Clinical and Immunological Activity of AFFITOPE® AD02 in Patients with Early Alzheimer's DiseaseA Schneeberger, S Hendrix, M Mandler, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 21, 2004
Intravenous immunoglobulins containing antibodies against beta-amyloid for the treatment of Alzheimer's diseaseR C Dodel, Y Du, C Depboylu, et al.
The Journal of Nutrition, Health & Aging|June 5, 2012
A combination of galantamine and memantine modifies cognitive function in subjects with amnestic MCIO Peters, D Lorenz, A Fesche, et al.
The Journal of Nutrition, Health & Aging|March 6, 2009
Evolution of Abeta42 and Abeta40 levels and Abeta42/Abeta40 ratio in plasma during progression of Alzheimer's disease: a multicenter assessmentK Blennow, G De Meyer, O Hansson, et al.
Neurology|January 13, 2012
Biomarker validation of a cued recall memory deficit in prodromal Alzheimer diseaseM Wagner, S Wolf, F M Reischies, et al.
Neuroimage|December 17, 2002
Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PETK Herholz, E Salmon, D Perani, et al.
Dementia and Geriatric Cognitive Disorders|September 29, 2011
Regional differences in effects of APOE ε4 on cognitive impairment in non-demented subjectsJ Norberg, C Graff, O Almkvist, et al.
Experimental Neurology|August 12, 2009
Amyloid beta peptides in plasma in early diagnosis of Alzheimer's disease: A multicenter study with multiplexingP Lewczuk, J Kornhuber, E Vanmechelen, et al.
Molecular Psychiatry|July 30, 2008
Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer's disease: a multicenter studyP Lewczuk, H Kamrowski-Kruck, O Peters, et al.
Current Alzheimer Research|June 30, 2012
Progression of Alzheimer disease in Europe: data from the European ICTUS studyB Vellas, L Hausner, L Frölich, et al.
Pageof 10

Showing results (81-90 of 92) with videos related to

Sort By:
Pageof 10
The Journal of Prevention of Alzheimer'S Disease|December 13, 2017
Results from a Phase II Study to Assess the Clinical and Immunological Activity of AFFITOPE® AD02 in Patients with Early Alzheimer's DiseaseA Schneeberger, S Hendrix, M Mandler, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|September 21, 2004
Intravenous immunoglobulins containing antibodies against beta-amyloid for the treatment of Alzheimer's diseaseR C Dodel, Y Du, C Depboylu, et al.
The Journal of Nutrition, Health & Aging|June 5, 2012
A combination of galantamine and memantine modifies cognitive function in subjects with amnestic MCIO Peters, D Lorenz, A Fesche, et al.
The Journal of Nutrition, Health & Aging|March 6, 2009
Evolution of Abeta42 and Abeta40 levels and Abeta42/Abeta40 ratio in plasma during progression of Alzheimer's disease: a multicenter assessmentK Blennow, G De Meyer, O Hansson, et al.
Neurology|January 13, 2012
Biomarker validation of a cued recall memory deficit in prodromal Alzheimer diseaseM Wagner, S Wolf, F M Reischies, et al.
Neuroimage|December 17, 2002
Discrimination between Alzheimer dementia and controls by automated analysis of multicenter FDG PETK Herholz, E Salmon, D Perani, et al.
Dementia and Geriatric Cognitive Disorders|September 29, 2011
Regional differences in effects of APOE ε4 on cognitive impairment in non-demented subjectsJ Norberg, C Graff, O Almkvist, et al.
Experimental Neurology|August 12, 2009
Amyloid beta peptides in plasma in early diagnosis of Alzheimer's disease: A multicenter study with multiplexingP Lewczuk, J Kornhuber, E Vanmechelen, et al.
Molecular Psychiatry|July 30, 2008
Soluble amyloid precursor proteins in the cerebrospinal fluid as novel potential biomarkers of Alzheimer's disease: a multicenter studyP Lewczuk, H Kamrowski-Kruck, O Peters, et al.
Current Alzheimer Research|June 30, 2012
Progression of Alzheimer disease in Europe: data from the European ICTUS studyB Vellas, L Hausner, L Frölich, et al.
Pageof 10